CPEB4 and ovarian cancer: Therefore, these results support a promotive effect of CPEB4 overexpression on paclitaxel resistance in ovarian cancer cells, and also suggest that CPEB4 upregulation detected in paclitaxel-resistant cells (Figures 1A,B) may contribute to the development and maintenance of resistance.